Candel Therapeutics (CADL) Stock Surges: Regulatory Approval Sparks Investor Interest
Candel Therapeutics, Inc. (NASDAQ: CADL) experienced a significant surge in its stock valuation on the preceding trading day, showcasing an impressive increase of 42.75% and